Sarepta Therapeutics buy BiotechBee
Start price
29.10.23
/
50%
€17.90
Target price
31.03.26
€150.00
Performance (%)
-
End price
30.10.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sarepta Therapeutics | -1.540% | -1.540% | -66.379% |
| iShares Core DAX® | -1.741% | 5.666% | 7.839% |
| iShares Nasdaq 100 | 2.815% | 11.547% | 36.610% |
| iShares Nikkei 225® | -0.109% | 9.654% | 45.650% |
| iShares S&P 500 | 0.966% | 7.240% | 26.969% |
According to BiotechBee what are the pros and cons of Sarepta Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year